AAM
VNDA icon

Advisors Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Advisors Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,330
Closed -$11.7K – 1510
2025
Q4 		$11.7K Sell
1,330
-1,562
-54% -$8.6K ﹤0.01% 1377
2025
Q3 		$14.4K Sell
2,892
-428
-13% -$1.98K ﹤0.01% 1375
2025
Q2 		$15.7K Sell
3,320
-81
-2% -$354 ﹤0.01% 1359
2025
Q1 		$15.6K Sell
3,401
-232
-6% -$1.08K ﹤0.01% 1376
2024
Q4 		$17.4K Buy
3,633
+1,939
+114% +$9.31K ﹤0.01% 1387
2024
Q3 		$7.95K Buy
+1,694
New +$9.08K ﹤0.01% 1419

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisors Asset Management's VNDA Position: Q1 2026 in Review

Advisors Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 1,330 shares — an estimated $11.7K sold.

Advisors Asset Management first reported a position in VNDA in Q3 2024 and held it in 6 quarters. The position peaked at $17.4K in Q4 2024. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Advisors Asset Management reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Advisors Asset Management sold 1,330 Vanda Pharmaceuticals shares in Q1 2026, an estimated $11.7K.
  • Advisors Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Advisors Asset Management's Vanda Pharmaceuticals position peaked at $17.4K in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.